Access July News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Access July. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Access July Today - Breaking & Trending Today

BeiGene Presents Results from Phase 3 Trial of Tislelizumab in Nasopharyngeal Cancer at ESMO Immuno-Oncology Congress 2021

Published: December 10, 2021

In RATIONALE 309, tislelizumab in combination with chemotherapy significantly prolonged progression-free survival for patients, with survival benefit observed across patient subgroups The safety

Source: finanznachrichten.de

Related Topics:

United StatesYunpeng YangGabrielle ZhouYong BenOncology Esmoio CongressDrug AdministrationProfessor At Sun Yat Sen University Cancer CenterExchange CommissionTislelizumab Clinical ProgramChina National Medical Products AdministrationEuropean Society For Medical Oncology ImmunoBristol Myers SquibbEuropean SocietyMedical Oncology ImmunoChief Medical OfficerDrug EvaluationBiologics License ApplicationSun Yat Sen University Cancer CenterAbout NasopharyngealBiologics License ApplicationsNorth AmericaTislelizumab ClinicalHodgkin LymphomaMirati TherapeuticsPrivate Securities Litigation Reform Act